Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Feb;91(2):308–313. doi: 10.1111/j.1365-2249.1993.tb05900.x

Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.

A Ohsaka 1, S Kitagawa 1, A Yuo 1, K Motoyoshi 1, S Furusawa 1, Y Miura 1, F Takaku 1, M Saito 1
PMCID: PMC1554685  PMID: 7679062

Abstract

The superoxide (O2-)-releasing capacity in response to N-formyl-methionyl-leucyl-phenylalanine (FMLP) and the priming effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on FMLP-induced O2- release were investigated in neutrophils from 14 patients with myelodysplastic syndromes (MDS). The O2(-)-releasing capacity in MDS neutrophils varied from patient to patient. As compared with normal neutrophils, the O2(-)-releasing capacity in MDS neutrophils was increased in 9/14 patients, normal in three patients and decreased in two patients. There was no close relationship between the O2(-)-releasing capacity and the peripheral blood neutrophil count or the plasma concentration of C-reactive protein. The priming of neutrophils by rhG-CSF was not observed in five patients, whereas rhGM-CSF primed neutrophils from all patients. The priming effect of rhGM-CSF was consistently greater than that of rhG-CSF in each patient. The intravenous administration of rhG-CSF (300 micrograms/body) to two MDS patients showed an increase in the peripheral blood neutrophil count and enhancement of neutrophil O2- release. These findings demonstrate that the neutrophil O2(-)-releasing capacity in MDS varies from patient to patient and is not always impaired, and that rhGM-CSF is able to prime neutrophils which never respond to rhG-CSF.

Full text

PDF
308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antin J. H., Smith B. R., Holmes W., Rosenthal D. S. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood. 1988 Aug;72(2):705–713. [PubMed] [Google Scholar]
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun;51(2):189–199. [PubMed] [Google Scholar]
  3. Beris P. Primary clonal myelodysplastic syndromes. Semin Hematol. 1989 Jul;26(3):216–233. [PubMed] [Google Scholar]
  4. Boogaerts M. A., Nelissen V., Roelant C., Goossens W. Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol. 1983 Oct;55(2):217–227. doi: 10.1111/j.1365-2141.1983.tb01241.x. [DOI] [PubMed] [Google Scholar]
  5. Cebon J., Nicola N., Ward M., Gardner I., Dempsey P., Layton J., Dührsen U., Burgess A. W., Nice E., Morstyn G. Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity. J Biol Chem. 1990 Mar 15;265(8):4483–4491. [PubMed] [Google Scholar]
  6. Estey E. H., Kurzrock R., Talpaz M., McCredie K. B., O'Brien S., Kantarjian H. M., Keating M. J., Deisseroth A. B., Gutterman J. U. Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes. Br J Haematol. 1991 Mar;77(3):291–295. doi: 10.1111/j.1365-2141.1991.tb08573.x. [DOI] [PubMed] [Google Scholar]
  7. Fukunaga R., Seto Y., Mizushima S., Nagata S. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8702–8706. doi: 10.1073/pnas.87.22.8702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ganser A., Völkers B., Greher J., Ottmann O. G., Walther F., Becher R., Bergmann L., Schulz G., Hoelzer D. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial. Blood. 1989 Jan;73(1):31–37. [PubMed] [Google Scholar]
  9. Itoh Y., Kuratsuji T., Aizawa S., Sai M., Ohyashiki K., Toyama K. Superoxide anion production and expression of cytochrome b 558 by neutrophils are impaired in some patients with myelodysplastic syndrome. Ann Hematol. 1991 Nov;63(5):270–275. doi: 10.1007/BF01698377. [DOI] [PubMed] [Google Scholar]
  10. Kitagawa S., Yuo A., Souza L. M., Saito M., Miura Y., Takaku F. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun. 1987 May 14;144(3):1143–1146. doi: 10.1016/0006-291x(87)91430-6. [DOI] [PubMed] [Google Scholar]
  11. Kobayashi Y., Okabe T., Ozawa K., Chiba S., Hino M., Miyazono K., Urabe A., Takaku F. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. Am J Med. 1989 Feb;86(2):178–182. doi: 10.1016/0002-9343(89)90265-9. [DOI] [PubMed] [Google Scholar]
  12. Komiya I., Tanoue K., Kakinuma K., Kaneda M., Shinohara T., Kuriya S., Nomura T., Saito Y. Superoxide anion hyperproduction by neutrophils in a case of myelodysplastic syndrome. Association with Sweet's syndrome and interstitial pneumonia. Cancer. 1991 May 1;67(9):2337–2341. doi: 10.1002/1097-0142(19910501)67:9<2337::aid-cncr2820670921>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  13. Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med. 1992 Jul 2;327(1):28–35. doi: 10.1056/NEJM199207023270106. [DOI] [PubMed] [Google Scholar]
  14. Lopez A. F., Williamson D. J., Gamble J. R., Begley C. G., Harlan J. M., Klebanoff S. J., Waltersdorph A., Wong G., Clark S. C., Vadas M. A. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest. 1986 Nov;78(5):1220–1228. doi: 10.1172/JCI112705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Martin S., Baldock S. C., Ghoneim A. T., Child J. A. Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders. J Clin Pathol. 1983 Oct;36(10):1120–1128. doi: 10.1136/jcp.36.10.1120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. 1986 Jan 30-Feb 5Nature. 319(6052):415–418. doi: 10.1038/319415a0. [DOI] [PubMed] [Google Scholar]
  17. Negrin R. S., Haeuber D. H., Nagler A., Olds L. C., Donlon T., Souza L. M., Greenberg P. L. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial. Ann Intern Med. 1989 Jun 15;110(12):976–984. doi: 10.7326/0003-4819-110-12-976. [DOI] [PubMed] [Google Scholar]
  18. Ohsaka A., Kitagawa S., Sakamoto S., Miura Y., Takanashi N., Takaku F., Saito M. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood. 1989 Dec;74(8):2743–2748. [PubMed] [Google Scholar]
  19. Ohsaka A., Kitagawa S., Yuo A., Motoyoshi K., Ohta M., Miura Y., Takaku F., Saito M. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1992 Oct;20(9):1090–1093. [PubMed] [Google Scholar]
  20. Ohsaka A., Saito M., Suzuki I., Miura Y., Takaku F., Kitagawa S. Phorbol myristate acetate potentiates superoxide release and membrane depolarization without affecting an increase in cytoplasmic free calcium in human granulocytes stimulated by the chemotactic peptide, lectins and the calcium ionophore. Biochim Biophys Acta. 1988 Jun 7;941(1):19–30. doi: 10.1016/0005-2736(88)90209-x. [DOI] [PubMed] [Google Scholar]
  21. Okuda K., Sanghera J. S., Pelech S. L., Kanakura Y., Hallek M., Griffin J. D., Druker B. J. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood. 1992 Jun 1;79(11):2880–2887. [PubMed] [Google Scholar]
  22. Raines M. A., Golde D. W., Daeipour M., Nel A. E. Granulocyte-macrophage colony-stimulating factor activates microtubule-associated protein 2 kinase in neutrophils via a tyrosine kinase-dependent pathway. Blood. 1992 Jun 15;79(12):3350–3354. [PubMed] [Google Scholar]
  23. Ruutu P., Ruutu T., Vuopio P., Kosunen T. U., de la Chapelle A. Function of neutrophils in preleukaemia. Scand J Haematol. 1977 Apr;18(4):317–325. doi: 10.1111/j.1600-0609.1977.tb01202.x. [DOI] [PubMed] [Google Scholar]
  24. Souza L. M., Boone T. C., Gabrilove J., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruszewski J., Lu H., Chen K. K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986 Apr 4;232(4746):61–65. doi: 10.1126/science.2420009. [DOI] [PubMed] [Google Scholar]
  25. Vadhan-Raj S., Keating M., LeMaistre A., Hittelman W. N., McCredie K., Trujillo J. M., Broxmeyer H. E., Henney C., Gutterman J. U. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med. 1987 Dec 17;317(25):1545–1552. doi: 10.1056/NEJM198712173172501. [DOI] [PubMed] [Google Scholar]
  26. Watari K., Asano S., Shirafuji N., Kodo H., Ozawa K., Takaku F., Kamachi S. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 1989 Jan;73(1):117–122. [PubMed] [Google Scholar]
  27. Weisbart R. H., Golde D. W., Clark S. C., Wong G. G., Gasson J. C. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. 1985 Mar 28-Apr 3Nature. 314(6009):361–363. doi: 10.1038/314361a0. [DOI] [PubMed] [Google Scholar]
  28. Wong G. G., Witek J. S., Temple P. A., Wilkens K. M., Leary A. C., Luxenberg D. P., Jones S. S., Brown E. L., Kay R. M., Orr E. C. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science. 1985 May 17;228(4701):810–815. doi: 10.1126/science.3923623. [DOI] [PubMed] [Google Scholar]
  29. Yuo A., Kitagawa S., Kasahara T., Matsushima K., Saito M., Takaku F. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood. 1991 Nov 15;78(10):2708–2714. [PubMed] [Google Scholar]
  30. Yuo A., Kitagawa S., Motoyoshi K., Azuma E., Saito M., Takaku F. Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists. Blood. 1992 Mar 15;79(6):1553–1557. [PubMed] [Google Scholar]
  31. Yuo A., Kitagawa S., Ohsaka A., Ohta M., Miyazono K., Okabe T., Urabe A., Saito M., Takaku F. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood. 1989 Nov 1;74(6):2144–2149. [PubMed] [Google Scholar]
  32. Yuo A., Kitagawa S., Ohsaka A., Saito M., Takaku F. Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: qualitative and quantitative differences. Biochem Biophys Res Commun. 1990 Aug 31;171(1):491–497. doi: 10.1016/0006-291x(90)91420-w. [DOI] [PubMed] [Google Scholar]
  33. Yuo A., Kitagawa S., Okabe T., Urabe A., Komatsu Y., Itoh S., Takaku F. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood. 1987 Aug;70(2):404–411. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES